跳至主要内容
临床试验/CTRI/2017/11/010341
CTRI/2017/11/010341已完成未知

A Prospective Study to Explore the Role of Adipsin in the Mechanism of Glucose Intolerance Developed as an Adverse Effect of Statin Therapy

Dr Jahnavi Maini0 个研究点目标入组 55 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Treatment naive dyslipidemic patients (Low-density lipoprotein >=100mg/dl) or patients with ASCVD having dyslipidemia requiring statin therapy.

排除标准

  • 1.Patient with comorbid Type 1 and Type 2 Diabetes Mellitus.
  • 2.Patients prescribed lipid lowering agents other than statins.
  • 3.Any known history of condition(s) which may cause secondary dyslipidemia (e.g. nephrotic syndrome, glycogen storage disease etc.).
  • 4.Any history of condition(s) which may affect euglycemia (pancreatic impairment or disease).
  • 5.History of previous or current muscular or neuromuscular disease.
  • 6.History of drugs which impair lipid profile or glycemic parameters.

研究者

发起方
Dr Jahnavi Maini

相似试验